Quantitative structure-activity relationship study and directed synthesis of Thieno[2,3-d]pyrimidine-2,4-diones as monocarboxylate transporter 1 inhibitors

被引：0

作者：

O. T. Devinyak

Mikh. V. Slivka

Mar. V. Slivka

V. M. Vais

V. G. Lendel

机构：

[1] Uzhgorod National University,Department of Pharmaceutical Disciplines

[2] Uzhgorod National University,Department of Organic Chemistry

[3] Transcarpathian State University,undefined

来源：

Medicinal Chemistry Research | 2012年 / 21卷

关键词：

QSAR; Thieno[2,3-; ]pyrimidine-2,4-dione; Monocarboxylate transporter 1 inhibitor; -vinyl derivatives; In silico screening; Directed synthesis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The aim of any quantitative structure-activity relationship (QSAR) study is not only to reveal relationships between structure of molecules and their biological activity, but also to explain it within the bounds of theoretical conceptions and to use the obtained model for prediction of properties of new compounds. That provides possibility to execute directed synthesis of new compounds with required biological activities. Monocarboxylate transporter 1 (MCT1) is one of the targets in a search for new immune response modulating and antitumor agents. In the present study, QSAR model for MCT1 binding affinity is developed. Decisive influence of relative negative partial charge, solvation energy, and radius of gyration on MCT1 inhibition has been detected. Theoretical explanation of the obtained model is given, and biological activity prediction for a series of N-vinyl derivatives of thieno[2,3-d]pyrimidine-2,4-dione is made. Directed synthesis of three leading compounds has been executed according to prediction results.

引用

页码：2263 / 2272

页数：9

共 122 条

[1] Berchtold P(1996)Immunosuppression—a tightrope walk between iatrogenic harm and therapy Schweiz Med Wochenschr 38 1603-1609
[2] Seitz M(2008)Non-peptide gonadotropin-releasing hormone receptor antagonists J Med Chem 51 3331-3348
[3] Betz SF(1980)Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges Tetrahedron 36 3219-3228
[4] Zhu Y(2007)Principles of QSAR models validation: internal and external QSAR Comb Sci 26 694-701
[5] Chen C(2006)Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds Bioorg Med Chem Lett 16 2260-2265
[6] Struthers RS(1999)The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation Biochem J 343 281-299
[7] Gasteiger J(2004)Syntesis and reactivity of 1-bromomethyl-5-oxo-4-phenyl-1, 2, 4, 5, 6, 7, 8, 9-octahydrobenzo[4, 5]thieno[3, 2-e][1, 3]oxazolo[3, 2-a]-pyrimidin-11-ium bromides Zhurnal Organicheskoi Khimii 40 1705-1706
[8] Marsili M(2007)Benchmarking of QSAR models for blood-brain barrier permeation J Chem Inf Model 47 1648-1656
[9] Gramatica P(2008)Statistical Confidence for Variable Selection in QSAR models via Monte Carlo Cross-Validation J Chem Inf Model 48 370-383
[10] Guile SD(1997)Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 23 3-25

← 1 2 3 4 5 6 7 8 9 10 →